AGP Executive Report
Last update: 11 hours agoEbola figures revised: The WHO and DRC health authorities cut the number of suspected Ebola cases under investigation to 116 after lab testing ruled out hundreds of “Ebola-like” illnesses, while confirmed cases climbed to 321 (48 deaths) and six recoveries were reported. Response under pressure: WHO chief Tedros Ghebreyesus warned the outbreak is “very complex” and can be stopped only with stronger health-system capacity, community trust, and international solidarity—adding that travel bans and border closures risk slowing response and reducing transparency. Aid and access gaps: MSF says the situation is “deeply alarming,” with hundreds of samples still untested and containment delayed by conflict, insecurity, and closures. China steps in: A Chinese anti-epidemic medical expert team arrived in Kinshasa for a three-month mission to support Ebola prevention, control, and treatment. New prevention push: Moderna is advancing an mRNA vaccine for the Bundibugyo strain with CEPI funding, while WHO guidance includes testing a 10-day antiviral pill approach for exposed people. Tech & policy beyond health: DRC approved higher royalties for strategic minerals, including lithium and cobalt-linked inputs, as Kinshasa seeks more revenue from critical minerals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
